1. Glioblastoma Multiforme SSEA1+ CD133+
Lung Cancer
Sca+CD45-Pecam-CD34+
Breast Cancer
CD44+CD24-ESA+
CD44+CD24low/-
CD34+CD38-
Acute Myeloid Leukaemia
Acute Lymphoid Leukaemia
CD34+CD19-
CD133+CD44+
Gastric Cancer
CD133+ESAhighCD44+
CD166+
CD26+
Colorectal Cancer
Liver Cancer
CD90+
Pancreatic Cancer
CD44+CD24+ESA+
CD44+
Prostate Cancer
Bladder Cancer
Title: “Characteristic pattern”  I would avoid to say this since there is no so much a characteristic pattern of markers, as different combinations of markers that are currently in use to identify CSCs
 Bold: I have added some more markers from more papers
Underlined: I have added more types of cancers
Breast cancer: I also found CD44+/CD24low/Lin-/CD133+ (Al Hajj et al, PNAS 2003)
Head and Neck: CD44+ or CD44+/CD24+ (Prince M et al., PNAS 2007)
Melanoma: CD133+/CD166+ (Quintana et al., Nature 2008).
Colorectal cancer: ESAhigh/CD44+/CD166+ or ESAhigh/CD44+ or ESAhigh/CD166+ or CD44+/CD166+
(Dalerba P et al, PNAS 2007).
CD133+ alone (Ricci-Vitiani L et al., Nature 2007)
Lgr5+ (Barker et al., Nature 2007)
Ovarian cancer: CD133+ (Silva 2011)
Prostate cancer: CD44+/a2b1high/CD133+ (Collins et al., 2005)
Pancreatic cancer: CD44+ alone (Li C et al., Cancer Res 2007)
Bone sarcoma: Stro-1+/CD44+/CD105 (Gibbs et al., 2005)
AML: also: CD34+/CD38+/CD90-/CD71-/HLA-/DR-/CD117- in different combinations (Blair and Sutherland 2000)(Blair et al, 1997, 1998, Jordan et al, 2000).
NSCLC (can be part of lung cancer): CD133+/CD44+/epcam+/CD166+ (Zhang et al, 2012)
CD166(+)/CD44(+) or CD166(+)/EpCAM(+) (Zakaria et al, BMC cancer 2015)
Lung cancer: also: CD44+/CD90+ (Wang et al., Plos one 2013), CD133+CD44+ (Zhang et al, Mol Cell Biol 2010)
Brain tumors: Can include Glioma, Glioblastoma multiforme, Medulloblastoma  also I found:
CD133+/a6 integrin
Suggestion: It would be easier for the reader if we would put the reference number next to each one of those combinations of markers , in order to be able to associate what they read with the correspondent paper